Mariner’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Sell
1,325
-185
-12% -$38.3K ﹤0.01% 2976
2025
Q4
$312K Buy
1,510
+113
+8% +$22.6K ﹤0.01% 2806
2025
Q3
$250K Sell
1,397
-1,328
-49% -$226K ﹤0.01% 2971
2025
Q2
$440K Buy
2,725
+1,467
+117% +$234K ﹤0.01% 2437
2025
Q1
$214K Buy
+1,258
New +$218K ﹤0.01% 2941
2024
Q1
Sell
-1,712
Closed -$271K 3164
2023
Q4
$271K Buy
+1,712
New +$246K ﹤0.01% 2438
2023
Q3
Sell
-1,316
Closed -$202K 2940
2023
Q2
$202K Sell
1,316
-27
-2% -$4.21K ﹤0.01% 2459
2023
Q1
$208K Sell
1,343
-59
-4% -$9.27K ﹤0.01% 2388
2022
Q4
$216K Buy
+1,402
New +$207K ﹤0.01% 2291
2022
Q1
Sell
-14,280
Closed -$2.31M 1388
2021
Q4
$2.31M Buy
+14,280
New +$2.31M 0.01% 625
2016
Q4
Sell
-110
Closed -$11K 635
2016
Q3
$11K Buy
+110
New +$10.8K ﹤0.01% 727

Other funds holding FBT

Mariner's FBT Position: Q1 2026 in Review

Mariner reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 12% in Q1 2026, selling an estimated $38.3K and leaving 1,325 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Mariner first reported a position in FBT in Q3 2016 and has held it in 11 quarters since. The position peaked at $2.31M in Q4 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Mariner held 1,325 shares of First Trust NYSE Arca Biotechnology Index Fund worth $266K as of Q1 2026.
  • Mariner sold 185 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $38.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2976 holding.
  • Mariner first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2016 and has held it in 11 quarters since.
  • Mariner's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.31M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.